← Back to patent-cliff list
L-赖氨酸盐酸盐/L-精氨酸盐酸盐
Tier C — Watch / tradeL-Arginine hydrochloride/L-Lysine hydrochloride
Advanced Accelerator Applications Sa
Originator
2019
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Updating
Brand：LysaKare
Indications (approved)：辐射损伤
Regional status
US
-
EU
批准上市
2019-07-25
China
-
Japan
批准上市
2021-06-23
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of L-Arginine hydrochloride/L-Lysine hydrochloride?
Approved indications include: 辐射损伤.
When does the L-Arginine hydrochloride/L-Lysine hydrochloride patent expire?
No public expiry year is available for L-Arginine hydrochloride/L-Lysine hydrochloride yet; this page updates once verified.
How do I get a quote for L-Arginine hydrochloride/L-Lysine hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24